Period of time： 2014年1期
Publisher： Informa Healthcare
Founded in： 2006
Total resources： 77
ISSN： 1746-0441
Subject： R9 Pharmacy
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Expert Opinion on Drug Discovery,volume 3,issue 1
Menu
By Smalley Keiran SM,Lioni Mercedes,Noma Kazuhiro,Haass Nikolas K,Herlyn Meenhard in (2008)
Expert Opinion on Drug Discovery,volume 3,issue 1 , Vol. 3, Iss. 1, 2008-01 , pp.
Access to resources
Recommend
Huprines for Alzheimer's disease drug development
By Muñoz-Torrero Diego,Camps Pelayo in (2008)
Expert Opinion on Drug Discovery,volume 3,issue 1 , Vol. 3, Iss. 1, 2008-01 , pp.Animal models for drug discovery in dystonia
By Jinnah HA,Richter Angelika,Mink Jonathon W,Caldwell Guy A,Caldwell Kim A,Gonzalez-Alegre Pedro,Cookson Mark R,Breakefield Xandra O,Delong Mahlon R,Hess Ellen J in (2008)
Expert Opinion on Drug Discovery,volume 3,issue 1 , Vol. 3, Iss. 1, 2008-01 , pp.Discovery and development of purine-scaffold Hsp90 inhibitors
By Chiosis Gabriela,Kang Yanlong,Sun Weilin in (2008)
Expert Opinion on Drug Discovery,volume 3,issue 1 , Vol. 3, Iss. 1, 2008-01 , pp.Developing assays for kinase drug discovery – where have the advances come from?
By Vogel Kurt W,Zhong Zhong,Bi Kun,Pollok Brian A in (2008)
Expert Opinion on Drug Discovery,volume 3,issue 1 , Vol. 3, Iss. 1, 2008-01 , pp.Seliciclib, a cell-cycle modulator that acts through the inhibition of cyclin-dependent kinases
By Jackson Robert C,Barnett Anna L,McClue Steven J,Green Simon R in (2008)
Expert Opinion on Drug Discovery,volume 3,issue 1 , Vol. 3, Iss. 1, 2008-01 , pp.